Net profit of Concord Biotech declined 36.27% to Rs 62.90 crore in the quarter ended September 2025 as against Rs 98.70 crore during the previous quarter ended September 2024. Sales declined 20.35% to Rs 247.06 crore in the quarter ended September 2025 as against Rs 310.18 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended |
| Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 247.06 | 310.18 | -20 |
| OPM % | 36.65 | 44.06 | - |
| PBDT | 103.92 | 146.60 | -29 |
| PBT | 85.53 | 133.29 | -36 |
| NP | 62.90 | 98.70 | -36 |